Stock Analiz

BridgeBio Pharma, Inc. (BBIO) stock forecast and price target

Price $78.30 · data as of November 13, 2026

12-month price target

Average target$107.00
Upside / downside+36.7%
Analysts20
ConsensusStrong buy
Low $80.00Average $107.00High $156.00

Gold marker: average target · white marker: today’s price ($78.30)

Analyst ratings

Strong buy 5Buy 14Hold 3Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-2.45+35.4%$1.1B
Next fiscal year
ends December 31, 2027
$-0.27+88.8%$1.7B
Next quarter
ends December 31, 2026
$-0.50+46.3%$304M
Quarter after
ends March 31, 2027
$-0.37+56.2%$338M

Consensus of the analysts covering BridgeBio Pharma, updated daily. In the last 30 days 5 estimates were raised and 0 lowered.

Frequently asked questions

What is the BridgeBio Pharma stock price target?

The average 12-month target from 20 analysts is $107.00, 36.7% above the current price of $78.30 Targets range from $80.00 to $156.00.

Is BridgeBio Pharma a buy according to analysts?

The consensus rating is “Strong buy” (5 strong buy, 14 buy, 3 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is BridgeBio Pharma expected to earn?

Analysts expect EPS of $-2.45 for the fiscal year ending December 31, 2026 and $-0.27 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.